IP Verse

Ter Meer Steinmeister & Partner Patentanwalte Mbb patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest oppositions filed by Ter Meer Steinmeister & Partner Patentanwalte Mbb

Explore patent oppositions filed by Ter Meer Steinmeister & Partner Patentanwalte Mbb against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2662094
Cylodextrin Complexation Methods For Formulating Peptide Proteasome InhibitorsONYX THERAPEUTICSJan 17, 2025
EP3150200
Pharmaceutical Composition, Pharmaceutical Dosage Form, Process For Their Preparation, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMJan 10, 2025
EP3313408
Drospirenone-Based Contraceptive For A Female Patient Affected With Excess WeightLABORATORIOS LEON FARMASep 5, 2024
EP3702351
Formulation Comprising A Mek InhibitorARRAY BIOPHARMAAug 21, 2024
EP3210978
Process For Producing Acesulfame PotassiumCELANESE SALES GERMANYJun 6, 2024
EP3856341
Crystalline Forms Of (S)-1-(4-Fluorophenyl)-1-(2-(4-(6-(1-Methyl-1H-Pyrazol-4-Yl)Pyrrolo[2,1-F][1,2,4]Triazin-4-Yl)Piperazinyl)-Pyrimidin-5-Yl)Ethan-1-Amine And Methods Of MakingBLUEPRINT MEDICINESJun 5, 2024
EP2760509
Use Of Plasma Treated Silicone Oil As A Coating In A Medical Injection DeviceBECTON DICKINSON FRANCEJan 2, 2024
EP3811943
Compound For Use In The Treatment Of Ocular DisordersAERIE PHARMACEUTICALSNov 22, 2023
EP3463345
Pharmaceutical CombinationsARRAY BIOPHARMAAug 1, 2023
EP3554536
Recombinant Hvt Vectors Expressing Multiple Antigens Of Avian Pathogens, And Vaccines Comprising ThemBOEHRINGER INGELHEIM ANIMAL HEALTH USAJul 26, 2023

Top competitors of Ter Meer Steinmeister & Partner Patentanwalte Mbb

List of top competitors of Ter Meer Steinmeister & Partner Patentanwalte Mbb based on patent oppositions.